Schonfeld Strategic Advisors LLC Replimune Group, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $12.5 Billion
- Q2 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 234,806 shares of REPL stock, worth $1.23 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
234,806
Previous 458,672
48.81%
Holding current value
$1.23 Million
Previous $4.47 Million
51.23%
% of portfolio
0.02%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding REPL
# of Institutions
195Shares Held
77.7MCall Options Held
2.06MPut Options Held
2.86M-
Baker Bros. Advisors LP New York, NY11MShares$58 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$56.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$24.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$24.5 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$20.5 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $259M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...